Resverlogix Corp. (RVXCF) Financials
RVXCF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 8.0 million | 98.6 million |
| Dec. 31, 2025 | 7.9 million | 96.7 million |
| Sept. 30, 2025 | 7.8 million | 96.7 million |
| June 30, 2025 | 7.7 million | 95.8 million |
RVXCF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -975301 | ? |
| Dec. 31, 2025 | -1.0 million | ? |
| Sept. 30, 2025 | -913000 | 94000 |
| June 30, 2025 | -1.0 million | 160000 |
RVXCF Net Income
No data available :(
RVXCF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 50164 | 53.4 million | - |
| Dec. 31, 2025 | 107803 | 52.0 million | - |
| Sept. 30, 2025 | 64000 | - | 42000 |
| June 30, 2025 | 12000 | 56.1 million | 42000 |
RVXCF Shares Outstanding
RVXCF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 614370 | 472365 | - |
| Dec. 31, 2025 | 9158 | 918911 | 537131 | - |
| Sept. 30, 2025 | 95000 | 608182 | 420288 | - |
| June 30, 2025 | 107000 | 715000 | 571000 | - |
RVXCF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 78891 |
| Dec. 31, 2025 | - | 120283 |
| Sept. 30, 2025 | - | 105813 |
| June 30, 2025 | - | 107746 |
RVXCF
Price: $0.07
52 week price:
Earnings Per Share: -0.03 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 22.2 million